Puz, P., & Lasek-Bal, A. (2016). Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients. Med Sci Monit.
Citação norma ChicagoPuz, Przemysław, and Anetta Lasek-Bal. "Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based On the Treatment of Forty-Four Patients." Med Sci Monit 2016.
Citação norma MLAPuz, Przemysław, and Anetta Lasek-Bal. "Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based On the Treatment of Forty-Four Patients." Med Sci Monit 2016.